Xaira
Facts
- HQ
- San Francisco, California, USA; Seattle, Washington, USA
- Sectors
- Biotechnology, AI, Drug discovery
- Stage
- Seed
Seattle’s UW research, Amazon alumni and military adjacency fuel startups building high-stakes, regulation-ready AI for biotech, finance and government
A Seattle high-school intern argues that strict school AI rules illuminated why AI must be disciplined in high-stakes domains, and describes how Seattle's research institutions (notably UW and the David Baker ecosystem), Amazon alumni, and military adjacency produce founders building accountable, regulation-ready AI for biotech, finance, and government.
Seattle Startup Pauling.AI Uses AI to Cut Drug Discovery from Months to Weeks, Founded by Ex-Google Exec Javier Tordable in 2024
Seattle startup Pauling.AI uses AI to automate early drug discovery steps, reducing timelines from months to weeks and aiming to greatly increase new drug approvals. Founded in 2024 by former Google technical director Javier Tordable, the company offers a 'scientist-as-a-service' platform to assist researchers with computational chemistry and drug candidate modeling.
Jeff Bezos Named Co-CEO of $6.2 Billion Funded AI Startup Project Prometheus in Return to Executive Role
Jeff Bezos has become co-CEO of Project Prometheus, a secretive AI startup with $6.2 billion in funding focused on AI for the physical economy, marking his first operational executive role since leaving Amazon's CEO position in 2021. The startup, co-led by Vik Bajaj, aims at applications in computers, automobiles, and aerospace with potential collaboration opportunities with Amazon.
Fred Hutch-Led Synthesize Bio Raises $10M to Accelerate Drug Discovery Using AI Gene Expression Model
Seattle-based Synthesize Bio, led by Fred Hutchinson Cancer Center researchers, raised $10 million from Madrona to accelerate drug discovery using their AI model GEM-1, which predicts gene expression outcomes with lab-level accuracy. The startup aims to reduce drug development time and costs by simulating hypothetical lab experiments with generative genomics.
Seattle VCs Forecast AI Dominance and Crypto Skepticism in 2025 Tech Landscape
Seattle venture capitalists predict AI will dominate tech trends in 2025, emphasizing its integration into consumer interactions and infrastructure. While AI is expected to advance, some also view crypto as the most overhyped technology.
Nobel Laureate David Baker Drives Protein Design Innovation and Startup Growth at University of Washington
David Baker, Nobel Prize winner and head of the Institute for Protein Design at the University of Washington, is focused on advancing protein design research and entrepreneurship, having helped spawn over 20 startups in Seattle's biotech hub. He plans to continue accelerating scientific innovation in the field, which develops new proteins for therapeutics, vaccines, and materials.
